14 May 2021
14 May 2021
06 May 2021
Henrique Veiga-Fernandes, Immunologist, Principal Investigator and one of the Directors of Champalimaud Research; and Ana Paula Pêgo, group leader at i3S - Institute for Research and Innovation in Health, now join an elite group of world-renowned scientists on the Science Review Editors Council.
20 April 2021
In many species, including humans and mice, the fluctuating levels of the hormones progesterone and estrogen determine whether the female is fertile or not. And in the case of mice, whether she’s sexually receptive or not.
The change in receptivity is striking. Female mice shift from accepting sexual partners to aggressively rejecting them across a cycle of six short days. How can the female reproductive hormones bring about such a radical behavioural change?
This workshop brings together agency, regulator, industry and primary researcher communities in biomedical sciences to talk freely about methods and models and explore common ground.
This is a Champalimaud Foundation workshop co-organised with CONGENTO and QuantOCancer projects, the Joint Research Centre (JRC) and FRESCI.
During this event we will:
25 March 2021
For the first time, this Ar Event was available solely online, but that didn’t stop viewers from interacting on all of the available platforms - Zoom, Facebook Live and YouTube - with more than 200 questions shared with our panel of experts. According to Dr. Bill Richards (who you’ll get to know later!), we are “Moving into new terrain… and we welcome you to join us!”
24 March 2021
This Gulbenkian Knowledge Academy is looking for young people ready to embark on an intergalactic journey into the future of neuroscience!
In this edition, candidates will be able to choose one of two possible trips - Long Flight (lasting about 4 weeks) or Short Flight (lasting around 2 weeks). For the first, 16 Neurocadets will be recruited and for the second, 8 Chimeras!
10 March 2021
The starting point for the discussion was the “Inside the Unknown” Science Collection, a project developed by this group in collaboration with Champalimaud Research Labs. The genesis of the project, the creative process behind it, the articulation of all the team’s expertises, main challenges and evaluation metrics, were some of the topics addressed in this conversation.
05 March 2021
Champalimaud Foundation’s work with artificial intelligence is the fourth best in the worldIn the Nature TOP 10, there are institutions from Germany, the United States of America, Portugal, the Netherlands, Spain and the United Kingdom. According to Leonor Beleza, President of the Champalimaud Foundation, “it is a great honour for Portugal and for the Champalimaud Foundation to be at the forefront of scientific research”.
For millennia, humans have “tripped” on psychedelic substances for spiritual growth, healing or recreational purposes. Today, the healthcare community has renewed interest in the potential of psychedelics for mental health.
In this Ar event, Tiago Quendera and Tatiana Silva, two neuroscience PhD students at the Champalimaud Centre for the Unknown, will take you through the ups and downs of the history of psychedelics and their use in research.
CRS21 will focus on the interface of neuroscience, artificial intelligence and machine learning with the main goal of starting an interdisciplinary conversation about the deep conceptual problems that emerge when trying to understand how intelligent behaviour is generated in animals and machines.